What is the diagnostic approach for mesothelioma?

What is the diagnostic approach for mesothelioma?

• A. CT chest showing pleural thickening and VATS pleural biopsy
• B. MRI brain
• C. Ultrasound of abdomen
• D. PET-CT only

Answer: (A)

The main idea is that diagnosing mesothelioma requires tissue confirmation, with imaging guiding where to biopsy. A CT scan of the chest that shows pleural thickening (often with nodularity, rind-like encasement, or associated effusion) raises suspicion for mesothelioma, but it cannot prove the diagnosis on its own. Obtaining an adequate tissue sample is essential for histology and immunohistochemistry to distinguish mesothelioma from other malignant or benign pleural processes. Video-assisted thoracoscopic surgery (VATS) pleural biopsy provides direct visualization of the pleura and allows multiple, representative tissue samples to be taken from different pleural areas. This yields a much higher diagnostic accuracy than needle or percutaneous biopsy alone, and it enables the pathologist to perform the necessary immunohistochemical panel to confirm mesothelioma and determine the histologic subtype. Other options, like MRI of the brain or abdominal ultrasound, do not address the primary need for tissue confirmation in mesothelioma. A PET-CT can help with staging and assessing metabolic activity but cannot establish the diagnosis by itself; histologic proof is still required. So, combining CT-chest evidence of pleural disease with a VATS pleural biopsy provides the strongest, most definitive diagnostic approach.

The main idea is that diagnosing mesothelioma requires tissue confirmation, with imaging guiding where to biopsy. A CT scan of the chest that shows pleural thickening (often with nodularity, rind-like encasement, or associated effusion) raises suspicion for mesothelioma, but it cannot prove the diagnosis on its own. Obtaining an adequate tissue sample is essential for histology and immunohistochemistry to distinguish mesothelioma from other malignant or benign pleural processes.

Video-assisted thoracoscopic surgery (VATS) pleural biopsy provides direct visualization of the pleura and allows multiple, representative tissue samples to be taken from different pleural areas. This yields a much higher diagnostic accuracy than needle or percutaneous biopsy alone, and it enables the pathologist to perform the necessary immunohistochemical panel to confirm mesothelioma and determine the histologic subtype.

Other options, like MRI of the brain or abdominal ultrasound, do not address the primary need for tissue confirmation in mesothelioma. A PET-CT can help with staging and assessing metabolic activity but cannot establish the diagnosis by itself; histologic proof is still required.

So, combining CT-chest evidence of pleural disease with a VATS pleural biopsy provides the strongest, most definitive diagnostic approach.